PAVmed Inc logo

PAVM

PAVmed Inc

$1.26

Earnings Summary

Revenue
$0.3Mn
Net Profits
$-17.5Mn
Net Profit Margins
-5833.67%

Highlights

Revenue:

PAVmed Inc’s revenue jumped +Inf% since last year same period to $0.3Mn in the Q1 2022. On a quarterly growth basis, PAVmed Inc has generated 0% jump in its revenue since last 3-months.

Net Profits:

PAVmed Inc’s net profit fell -85.57% since last year same period to $-17.5Mn in the Q1 2022. On a quarterly growth basis, PAVmed Inc has generated -1.64% fall in its net profits since last 3-months.

Net Profit Margins:

PAVmed Inc’s net profit margin jumped NaN% since last year same period to -5833.67% in the Q1 2022. On a quarterly growth basis, PAVmed Inc has generated -1.64% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the PAVmed Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.23
EPS Estimate Current Year
-0.23

Highlights

EPS Estimate Current Quarter:

PAVmed Inc’s earning per share (EPS) estimates for the current quarter stand at -0.23 - a -21.05% fall from last quarter’s estimates.

EPS Estimate Current Year:

PAVmed Inc’s earning per share (EPS) estimates for the current year stand at -0.23.

Key Ratios

Key ratios of the PAVmed Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.2
Return on Assets (ROA)
-0.61
Return on Equity (ROE)
-1.16
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

PAVmed Inc’s earning per share (EPS) fell -53.85% since last year same period to -0.2 in the Q1 2022. This indicates that the PAVmed Inc has generated -53.85% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. PAVmed Inc’s return on assets (ROA) stands at -0.61.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. PAVmed Inc’s return on equity (ROE) stands at -1.16.

Dividend Per Share (DPS):

PAVmed Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-04-06
-0.19
-0.2
-5.26%

Company Information

PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation. PAVmed's diversified pipeline of products address unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities. Its five lead technologies provide groundbreaking approaches to carpal tunnel syndrome (CarpX™), precancerous conditions of the esophagus (EsoGuard™/EsoCheck™), vascular access (PortIO™), pediatric ear infections (DisappEAR™) and medical infusions (NextFlo™). The company is also developing innovative products in other areas, such as catheters and tissue ablation, while seeking to further expand its pipeline through engagements with clinician innovators and leading academic medical centers.

Organisation
PAVmed Inc
Headquarters
One Grand Central Place, New York, NY, United States, 10165
Employees
25
Industry
Health Technology